Browse the corpus

Glucagon, a polypeptide hormone, is an essential medication in the anti-hypoglycemic class and is crucial in managing various medical conditions. This drug is approved by the US Food and Drug Administration (FDA) for treating acute hypoglycemia and as a diagnostic aid during gastrointestinal imaging. Glucagon is effective in treating refractory anaphylaxis that does not respond to epinephrine, thereby highlighting its versatility in critical situations. The medication exerts its effects through glucagon receptors, increasing cAMP levels to stimulate glycogenolysis and gluconeogenesis, raising blood glucose levels. Glucagon has several off-label uses, including treating beta-blocker overdoses, serving as adjunctive therapy for calcium channel blocker overdoses, and managing esophageal food impaction. Glucagon serves as a valuable intervention for esophageal obstructions caused by food bolus impaction, which assists healthcare professionals in resolving such blockages. Glucagon can be administered via intravenous, intramuscular, subcutaneous, or intranasal routes. Common adverse effects include nausea, hypertension, and rare hypersensitivity reactions. This activity reviews the indications, mechanism of action, administration, and contraindications of glucagon, highlighting its pharmacological properties, potential adverse effects, off-label uses, optimal dosing strategies, and essential monitoring requirements. This activity provides healthcare providers with the knowledge and skills necessary to effectively treat patients receiving glucagon in various clinical scenarios. In addition, this activity also emphasizes the importance of interdisciplinary collaboration among healthcare providers to monitor glucose levels, manage hypoglycemia, and optimize dosing in overdose cases. Objectives: Identify the clinical indications for glucagon use, including its role in treating severe hypoglycemia, beta-blocker and calcium channel blocker overdoses, and esophageal food impactions. Implement glucagon administration protocols based on established guidelines for acute hypoglycemia, overdose management, and gastrointestinal imaging. Apply knowledge of glucagon's pharmacodynamics and off-label uses to guide therapeutic decisions in emergency settings.

Identify the clinical indications for glucagon use, including its role in treating severe hypoglycemia, beta-blocker and calcium channel blocker overdoses, and esophageal food impactions. Implement glucagon administration protocols based on established guidelines for acute hypoglycemia, overdose management, and gastrointestinal imaging. Apply knowledge of glucagon's pharmacodynamics and off-label uses to guide therapeutic decisions in emergency settings. Collaborate with interprofessional healthcare providers, including pharmacists, endocrinologists, and nurses, to optimize glucagon dosing, particularly in patients with complex conditions. Access free multiple choice questions on this topic.

Administering excessive doses of exogenous glucagon can lead to predictable adverse reactions requiring intervention, though such occurrences are rarely documented in the literature. While insulin antagonizes glucagon, it is generally not recommended for treating glucagon toxicity. The transient hyperglycemia associated with glucagon administration is rarely life-threatening, but iatrogenic rebound hypoglycemia poses a significant risk. Management of Overdose Treatment should prioritize mitigating the hypertensive response to glucagon using alpha-blocking agents and vasodilators.[22]

Glucagon is essential for treating various conditions, with hypoglycemic shock being the most common indication. Effective management of these conditions requires an interprofessional healthcare team led by specialty clinicians and advanced practice practitioners, supported by pharmacists for guidance, nurses or paramedics for administration, and the nursing staff and laboratory technicians for monitoring. Collaboration and coordination among the interdisciplinary healthcare team are essential to ensure the timely identification of at-risk patients who may benefit from glucagon administration, especially when first-line therapies have failed or are unavailable. Without timely intervention, morbidity and mortality from hypoglycemic shock, as well as beta-blocker and calcium channel blocker overdoses, can be significant.[1] Glucagon administration enhances gastrointestinal imaging by improving image clarity and increasing safety, as it has largely replaced anticholinergics in this context.[18][23] Pharmacists are crucial in determining the appropriate use and dosage of glucagon, particularly in high-stress situations where its administration may be necessary. Their consultation has been shown to increase the availability of glucagon for patients on insulin therapy.[24] Coordinated care by an interdisciplinary healthcare team should include: Clinicians who can order blood glucose levels, with nurses and technicians responsible for obtaining the necessary samples. Nurses and clinicians who monitor patients for signs of hypoglycemia, including tachycardia, diaphoresis, tremors, altered mentation, or coma. The patient should ingest carbohydrates and protein to prevent rebound hypoglycemia once they are able to protect their airway. Note: tachycardia may be absent in cases of beta-blocker and calcium channel blocker overdoses. A pharmacist should be consulted regarding glucagon infusions in the setting of an overdose.[5] A toxicologist should be consulted for all glucagon therapy in the setting of an overdose and engaged if a glucagon overdose is suspected. Patients requiring prompt intervention due to hypoglycemia, overdose, or imaging can be encountered throughout the hospital system and by the general public. Once the acute intervention has stabilized the patient, preventing relapse is crucial, as glucagon's duration of action is typically shorter than the underlying cause of the emergency.

Patients requiring prompt intervention due to hypoglycemia, overdose, or imaging can be encountered throughout the hospital system and by the general public. Once the acute intervention has stabilized the patient, preventing relapse is crucial, as glucagon's duration of action is typically shorter than the underlying cause of the emergency. Patients with diabetes experiencing hypoglycemic shock will likely require hospitalization and should also have prompt follow-up with their endocrinologist or managing physician shortly after discharge. In cases of suspected intentional overdose, the involvement of a caseworker and psychiatrist is recommended. A coordinated, interdisciplinary approach to patient care is essential for improving patient safety, access to care, and the safe administration of glucagon.